Researchers have discovered a protein variant that serves as a knob for regulating the body's innate immune response. The findings could lead to new therapies for Long COVID, autoimmune disorders, and ...
Since launching AVISE CTD in 2012, Exagen has produced an extensive body of peer-reviewed literature supporting the test’s clinical validity and utility. These publications and the 1,000,000 th ...
The hematology market is experiencing significant growth driven by the increasing prevalence of blood-related disorders, advancements in research and product development, and the rising number ...
According to the Center for Science in the Public Interest, the average American eats 200 pounds of red meat and poultry a ...
Why does the COVID-19 virus make some people sicker than others? For years, scientists have looked to a critical piece of ...
After years of debilitating bouts of fatigue, Beth VanOrden finally thought she had an answer to her problems in 2016 when ...
Wexford-based biopharmaceutical company Coeptis Therapeutics Holdings Inc. is diversifying itself by launching a new division ...
There’s an important distinction to be made between acute inflammation and chronic inflammation. Inflammation is your body’s ...
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria.
Cells in the immune system don't always fight; they often rest and wait for threats, like viruses or bacteria. When such ...
Cyrus Biotechnology announces potent in vivo redosability of an engineered IdeS protease for IgG-driven autoimmune disease.
Autoimmune diseases arise when the immune system mistakenly targets and damages the body’s cells and tissues as though they were foreign invaders. This widespread category of illnesses, such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback